Home > PJ (current issue) > Broad Spectrum | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7483 p710
22/29 December 2007

This article
Reprint   Photocopy

PDF 30K, Acrobat Reader

Comment

Building up pharmacy’s power base

By Stephen Goundrey-Smith

Stephen Goundrey-Smith is healthcare development manager, SGS PharmaSolutions

The Broad spectrum feature is open to any reader. Contributions of around 1,100 words commenting on topical issues may be posted to Graeme Smith, managing editor, or e-mailed to graeme.smith@pharmj.org.uk for consideration

During the past few months, there have been many, many letters in The Pharmaceutical Journal from disgruntled pharmacists on the various controversial issues that trouble the profession.

Such issues range from the substantial increase in the retention fee to the responsible pharmacist consultation, and from the loss of the category M margin to the rates charged by locum pharmacists.

Many of these issues reflect the ongoing debates that other professions, as well as pharmacy, have on matters related to the professional role, autonomy and value, and other political matters. Some of the underlying issues are by no means exclusive to pharmacy and, as a consequence, it is possible to view many of these letters with equanimity.

However, a recent letter described how a pharmacist wrote to his MP over the retention fee issue and how the MP’s response showed “how irrelevant we are to the powers that be in Westminster” (PJ, 24 November 2007, p587). Comments like this are rather more disturbing.

During the course of this year, several commentators have stressed the importance of political lobbying and have suggested that pharmacists are too self-effacing when it comes to selling themselves as providers of new services and health care initiatives. There are many who would suggest that pharmacists have only themselves to blame for their lack of relevance to the political powers and authorities.

However, there are many pharmacists who are active in public life and who are vociferous in their advocacy of the role of pharmacists in health care. There are equally many pharmacists who are innovators, adept at building relationships with local commissioners and developing new health care services and initiatives to meet local needs.

It cannot, therefore, be accurate to say that pharmacy’s marginalisation is entirely due to a lack of political astuteness on the part of practising pharmacists.

The real issue is the disempowerment that many pharmacists experience and the pharmacy profession’s quest for relevance must begin with a move to build up the profession’s power base.

Recently, taxi drivers in Banbury, Oxfordshire, went on strike on a Friday and Saturday night, as a result of Cherwell District Council’s decision to delimit the number of taxi licenses granted each year and the potential threat to the cabbies’ monopoly.

This action led to angry confrontations in the town centre between cabbies and would-be customers, extra buses being drafted in and a heightened police presence in the town. As a consequence, many people in Banbury are now aware of the relevance of taxi services in Banbury. And the Banbury taxi drivers gained the attention they sought, not by writing letters to their MP, or through tedious negotiation with the council, but by taking action as a united body, to protect their interests.

Although there is not an exact parallel with the pharmacy profession (and I am not suggesting that pharmacists go on strike to bring their plight to the attention of the powers-that-be), pharmacists need to build up their power base and learn to develop and protect their professional interests. At first sight, this might fly in the face of the multidisciplinary team approach that health professions are increasingly encouraged to take.

However, sadly, for the majority of community pharmacists, collaboration with other primary care health professionals is an illusion. The medical profession is adept at protecting its own interests and the nursing profession has become adept at advancing its standing.

The pharmacy profession must do the same if it is to survive as a recognisable profession. Pharmacists will need to address a number of issues if they are to regain the status and role that, as members of a profession, they should have.

First, the pharmacy profession is fragmented, not united. The Royal Pharmaceutical Society has been heavily criticised for failing to advance the standing of pharmacists, instead finding new ways to take their money and discipline them. Consequently, many pharmacists feel a greater affiliation to their employer, rather than to their professional body.

In addition, there is a heterogeneous body of locum pharmacists who have no allegiance to anyone, except perhaps themselves and maybe the Pharmacists Defence Association.

Secondly, it is a fact that many pharmacists — especially employee and locum pharmacists — do not have ultimate control over their practice. The practice of community pharmacy is largely under the auspices of large retail organisations, whose business objectives may not be aligned with those of the pharmacy profession and where pharmacists are often valued as managers rather than as pharmacists.

The role of the pharmacist is likely to become more irrelevant in this organisational situation with the proposed changes in the supervision regulations.

Third, for many pharmacists, particularly in the community, the reality of pharmacy practice does not reflect their unique expertise and knowledge base. The medicines management process is about the development, formulation, supply and use of medicines, together with counselling and provision of information about medicines-related issues.

Pharmacists have the knowledge and training to be involved in the development and formulation of medicines and, although many pharmacists are indeed working in these areas, the influence of the pharmacy profession in the pharmaceutical industry has declined, for reasons that are beyond the scope of this article.

Pharmacists should be concerned with the counselling of patients and the provision of advice on medicines but often, in community pharmacy, these important areas of activity are squeezed out by the sheer volume of prescriptions that many pharmacies are processing. This is undoubtedly one of the reasons why growth of medicines-use-review and enhanced-services activity has been slow.

Consequently, all too often, the practice of pharmacy focuses only on the supply element of the medicines management process. And yet, with the growth of e-commerce technology, this aspect of pharmacy practice is one that could so easily be taken on by any number of non-specialist logistics companies. What is more, when the supervision regulations have been changed, many pharmacy multiples may look at doing exactly that.

Pharmacists need to consider how they can re-engineer their practice in order to make the most of the knowledge and skills that only they have. Only by doing this will they begin to build up their professional interests.

This will involve thinking outside the box and considering business models that are radically different to the retail model that community pharmacy currently conforms to. It is an urgent priority — especially for locum pharmacists who, in contrast with contractors and employed pharmacists, may find themselves in the wilderness when the supervision regulations change.

However, if the pharmacy profession can build initiatives and services based on the unique skill set and expertise of pharmacists, then its professional interests will be strengthened and the quest for relevance will bear fruit.

Back to Top


©The Pharmaceutical Journal